Goldman Sachs’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.04M Sell
607,765
-37,601
-6% -$435K ﹤0.01% 2537
2025
Q1
$5.63M Buy
645,366
+400,430
+163% +$3.5M ﹤0.01% 2655
2024
Q4
$3.52M Sell
244,936
-216,296
-47% -$3.11M ﹤0.01% 3115
2024
Q3
$10.4M Buy
461,232
+205,869
+81% +$4.65M ﹤0.01% 2214
2024
Q2
$4.97M Sell
255,363
-30,783
-11% -$599K ﹤0.01% 2611
2024
Q1
$10.7M Sell
286,146
-86,727
-23% -$3.25M ﹤0.01% 1994
2023
Q4
$20.9M Buy
372,873
+1,815
+0.5% +$102K ﹤0.01% 1515
2023
Q3
$15.3M Sell
371,058
-297,471
-44% -$12.3M ﹤0.01% 1680
2023
Q2
$37.3M Buy
668,529
+283,432
+74% +$15.8M 0.01% 1122
2023
Q1
$21.5M Sell
385,097
-32,196
-8% -$1.8M ﹤0.01% 1478
2022
Q4
$15.2M Sell
417,293
-98,393
-19% -$3.59M ﹤0.01% 1817
2022
Q3
$14.7M Sell
515,686
-125,732
-20% -$3.58M ﹤0.01% 1834
2022
Q2
$29M Sell
641,418
-44,852
-7% -$2.03M 0.01% 1351
2022
Q1
$52.2M Buy
686,270
+485,997
+243% +$37M 0.01% 1052
2021
Q4
$29.8M Sell
200,273
-18,589
-8% -$2.77M 0.01% 1475
2021
Q3
$31.9M Sell
218,862
-317,619
-59% -$46.2M 0.01% 1390
2021
Q2
$105M Buy
536,481
+30,436
+6% +$5.96M 0.02% 612
2021
Q1
$91.6M Buy
506,045
+107,419
+27% +$19.4M 0.02% 630
2020
Q4
$56.4M Sell
398,626
-3,408
-0.8% -$483K 0.01% 889
2020
Q3
$50.1M Buy
402,034
+42,411
+12% +$5.29M 0.01% 865
2020
Q2
$32.1M Buy
359,623
+178,469
+99% +$15.9M 0.01% 1156
2020
Q1
$11.3M Buy
181,154
+81,798
+82% +$5.1M ﹤0.01% 1734
2019
Q4
$7.58M Sell
99,356
-42,790
-30% -$3.26M ﹤0.01% 2189
2019
Q3
$7.16M Buy
+142,146
New +$7.16M ﹤0.01% 2119